About PeptiVir

About company

PeptiVir, Inc., a biopharmaceutical company, engages in the development and commercialization of synthetic peptide-based vaccines for the prevention of viral diseases. Its products include PVI-1000, an influenza vaccine for protection against various seasonal and pandemic strains. PeptiVir, Inc. was incorporated in 2010 and is based in Aurora, Colorado.